AL-S Pharma AG, a clinical-stage biotechnology company discovering and developing human antibodies that target misfolded proteins implicated in amyotrophic lateral sclerosis (ALS), today announced the ...
Editor’s note: The Covid-19 Vaccine Frequently Asked Questions page has been retired. Updated information regarding Covid-19 vaccination may be found at the NEJM Covid-19 Vaccine Resource Center.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results